Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update

by · The Markets Daily

Applied DNA Sciences, Inc. (NASDAQ:APDN – Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 5,300,000 shares, an increase of 199.4% from the November 30th total of 1,770,000 shares. Based on an average daily trading volume, of 5,810,000 shares, the short-interest ratio is presently 0.9 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Applied DNA Sciences to a “sell” rating in a research report on Tuesday, September 17th.

Check Out Our Latest Stock Report on APDN

Applied DNA Sciences Stock Performance

Shares of Applied DNA Sciences stock traded up $0.00 during trading on Thursday, hitting $0.18. 2,100,200 shares of the stock were exchanged, compared to its average volume of 4,235,776. Applied DNA Sciences has a 12 month low of $0.12 and a 12 month high of $14.40. The stock’s fifty day moving average is $0.21 and its 200 day moving average is $0.59. The stock has a market cap of $9.41 million, a PE ratio of -0.02 and a beta of 0.47.

Applied DNA Sciences (NASDAQ:APDN – Get Free Report) last announced its quarterly earnings results on Tuesday, December 17th. The technology company reported ($0.32) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.01. Applied DNA Sciences had a negative net margin of 214.42% and a negative return on equity of 138.41%. Sell-side analysts anticipate that Applied DNA Sciences will post -1.8 EPS for the current fiscal year.

Institutional Trading of Applied DNA Sciences

An institutional investor recently bought a new position in Applied DNA Sciences stock. Jane Street Group LLC purchased a new position in Applied DNA Sciences, Inc. (NASDAQ:APDN – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 73,396 shares of the technology company’s stock, valued at approximately $48,000. Jane Street Group LLC owned 0.24% of Applied DNA Sciences at the end of the most recent quarter. Hedge funds and other institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Company Profile

(Get Free Report)

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.

See Also